Skip to content

ZNTLZENTALIS PHARMACEUTICALS INC

CUSIP 98943L107 · common stock

2 tracked investors held ZENTALIS PHARMACEUTICALS INC (ZNTL) at the end of Q3 2026, worth $13.1M in total. The largest holder was Adar1 Capital Management, with 0.4% of its portfolio.

Holders · Q3 2026
2
New holders
0
Value held
$13.1M
Quarter-end price (est.)
$2.77

Investors holding ZNTL · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.44%3,762,532$10.4MADD+476.4%
PRIMECAP Management
PRIMECAP Management Co
0.00%957,420$2.7MHOLD

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026200$13.1M$2.77
Q2 2026200$7.8M$4.85
Q1 2026200$2.6M$2.34
Q4 2025200$1.4M$1.35